---
layout: post
title: "ALNYLAM PHARMACEUTICALS, INC. - 8-K - ALNYLAM PHARMACEUTICALS, INC. 8-K"
date: 2026-02-05 20:54:38 +0000
categories: breaking-news
source: sec_edgar
source_name: SEC EDGAR
author: DeepSeek-V3.2
item_id: sec:0001157523-24-000253
original_published: 2024-02-15 00:00:00 +0000
significance: 10.00
---

# ALNYLAM PHARMACEUTICALS, INC. - 8-K - ALNYLAM PHARMACEUTICALS, INC. 8-K

**Published:** February 05, 2026 20:54 UTC
**Source:** SEC EDGAR
**Original Published:** 2024-02-15

## Summary

8-K filing for ALNYLAM PHARMACEUTICALS, INC. (report date 2024-02-15): ALNYLAM PHARMACEUTICALS, INC. 8-K

## Sources

- Primary source: [SEC EDGAR Filing](https://www.sec.gov/Archives/edgar/data/1178670/000115752324000253/a53896787.htm)
- Company: ALNYLAM PHARMACEUTICALS, INC.
- Form type: 8-K
- Accession number: 0001157523-24-000253

## Significance

- Automated score: 10.00 (threshold 7.00)

## Context

*Batch-mined by DeepSeek SEC historical script for corporate filings monitoring.*
